# Mei Li

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mei-li-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,640 |
| Field | Bone health and treatments |
| h-index | 22 |
| i10-index | 46 |
| Last Known Institution | Sun Yat-sen University |
| OpenAlex ID | https://openalex.org/A5100331895 |
| ORCID iD | 0000-0001-8634-2252 |
| Works | 146 |

## Researcher papers

- [Qwen3 Technical Report](https://scholariq.org/papers/qwen3-technical-report/)
- [High-activity chitosan/nano hydroxyapatite/zoledronic acid scaffolds for simultaneous tumor inhibition, bone repair and infection eradication](https://scholariq.org/papers/high-activity-chitosan-nano-hydroxyapatite-zoledronic-acid-scaffolds-for/)
- [Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer](https://scholariq.org/papers/accumulation-of-p62-is-associated-with-poor-prognosis-in-patients-with-triple/)
- [Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia](https://scholariq.org/papers/clinical-and-genetic-analysis-in-a-large-chinese-cohort-of-patients-with-x/)
- [Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients](https://scholariq.org/papers/clinical-characteristics-and-outcomes-of-castleman-disease-a-multicenter-study/)
- [Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades](https://scholariq.org/papers/association-of-ptprd-ptprt-mutation-with-better-clinical-outcomes-in-nsclc/)
- [Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist](https://scholariq.org/papers/discovery-of-incb3284-a-potent-selective-and-orally-bioavailable-hccr2/)
- [Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma](https://scholariq.org/papers/combining-serum-inflammation-indexes-at-baseline-and-post-treatment-could/)
- [Immune parameters associated with survival in metaplastic breast cancer](https://scholariq.org/papers/immune-parameters-associated-with-survival-in-metaplastic-breast-cancer/)
- [Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma](https://scholariq.org/papers/overexpression-of-leucine-aminopeptidase-3-contributes-to-malignant-development/)
- [Evaluation of Quality and Bone Microarchitecture Alterations in Osteopetrosis Patients: Assessed by HR-PQCT](https://scholariq.org/papers/evaluation-of-quality-and-bone-microarchitecture-alterations-in-osteopetrosis/)

## Researcher topics

- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Sun Yat-sen University](https://scholariq.org/institutions/sun-yat-sen-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.